From: In silico pathway analysis based on chromosomal instability in breast cancer patients
 | Patients | Controls | p-value |
---|---|---|---|
No. of subjects | 150 | 150 | Â |
Age (Mean ± SD) | 50.2 ± 11.5 | 49.2 ± 14.6 | 0.51 |
Mean (%) aberrant metaphases | 22.6 ± 12.3 | 12.5 ± 4.6 |  < 0.0001 |
Mean (%) metaphases with structural aberrations | 11.7 ± 10.8 | 4.5 ± 3.1 |  < 0.0001 |
Mean (%) metaphases with numerical aberrations | 9.5 ± 6.7 | 6.2 ± 3.5 |  < 0.0001 |
Mean (%) metaphases with both structural and numerical aberrations | 2.6 ± 2.0 | 2.6 ± 1.1 | 1.00 |
Mean(%) metaphases with acrocentric associations | 27.6 ± 14.7 | 28.9 ± 14.6 | 0.32 |